CD24 and neuroblastoma: Our studies revealed that the selectin ligand CD24 expression was higher in neuroblastomas compared to the more differentiated ganglioneuroma and ganglioneuroblastoma samples, whereas the converse was true of CD44. However, patients with higher CD44 and or CD24 in their tumors exhibited better trend of survival.